Gregory T Wolf MD

Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery, Facial Plastic Surgery

Professor of Otolaryngology, University Mich Medical School

Education & Training

National Cancer InstituteFellowship, Tumor Immunology, 1978 - 1980
SUNY Upstate Medical UniversityResidency, Otolaryngology - Head and Neck Surgery, 1975 - 1978
MedStar Health Georgetown University (D.C.)Residency, Surgery, 1973 - 1975
District of Columbia General HospitalResidency, Surgery, 1974 - 1974
University of Michigan Medical SchoolClass of 1973

Alpha Omega Alpha
Albert Nelson Marquis Lifetime Achievement Award 2018
President, American Head and Neck Society 2012
Distinguished Faculty Lectureship Award in Biomedical Research - (only surgeon to ever receive this award). University of Michigan, 2011
Albert C. Muse Prize in Medicine University of Pittsburgh - Eye and Ear, 2009
Inaugural Keynote Speaker -First Multidisciplinary Symposium on Head and Neck Cancer ASTRO, 2007
Nominated - Institute of Medicine Institute of Medicine, 2006
Senior Examiner American Board of Otolaryngology, 2000-2006
Council Member, NIDCD National Institutes of Health, 1997-2001
Garnett Passe and Rodney Williams Memorial Foundation Award Passe and Williams Foundation, Sydney, Australia, 1998
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACS) American College of Surgeons
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Join now to see all

PubMed

Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
William J Benjamin, Allen L Feng, Molly Heft Neal, Emily Bellile, Keith A Casper
Oral Oncology. 2024-09-01
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC.
Paul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron Udager
Clinical Cancer Research. 2024-06-03
Aspirin use and head and neck cancer survival and recurrence.
Xinman Zhang, Omar S Ilyas, Kayla R Getz, Laura S Rozek, Jeremy M G Taylor
Cancer Causes & Control. 2024-04-01

IRX Therapeutics Presents Positive IRX-2 Phase 2a Head and Neck Squamous Cell Carcinoma Clinical Results at the European Society for Medical Oncology Annual Congress 2017September 11th, 2017
Individualized Bioselection Treatment Methods Increase Survival Rates in Laryngeal CancerFebruary 13th, 2017

Co-investigator (5%) - Develop a Therapeutic Nano-vaccine against Head and Neck Cancer.NIH2018–2023
Co-Investigator (5%) - Statistical Methods for Cancer Biomarkers.NIH2017–2022
Co-Investigator (5%) - Development of a Prognostic Compound Immunoscore for Head and Neck CancerNIH2018–2020
Principal Investigator (50%) - Central Laboratory and Biorepository for INSPIRE: A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly DiagnoseBrooklyn Immunotherapeutics, Inc2015–2020
The Molecular Basis Of Head And Neck Cancer Biology, Treatment And PreventionNational Cancer Institute2008–2011
Role Of Soy Isoflavones, Smoking Abstinence And Molecular Markers In PreventionNational Cancer Institute2008–2011
Developmental Research ProgramNational Cancer Institute2008–2011
Career Development ProgramNational Cancer Institute2008–2011
C1: AdministrationNational Cancer Institute2008–2011
The Molecular Basis Of Head And Neck Cancer TherapyNational Cancer Institute2002–2007
Advanced Research Training In OtolaryngologyNational Institute On Deafness And Other Communication Disorders2002–2006
Research Training In The Communicative SciencesNational Institute On Deafness And Other Communication Disorders1995–2001